Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05350696Unknown
Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Sohag University. Primary endpoint: Postoperative analgesia at 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05350696.